Overview

  • Product nameAnti-BSCL2 antibody
    See all BSCL2 primary antibodies
  • Description
    Rabbit polyclonal to BSCL2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to a region within N terminal amino acids 85-115 of Human BSCL2 (NP_001116427.1, NP_001124174.1, NP_116056.3), conjugated to KLH.

  • Positive control
    • NCI-H460 cell line lysates

Properties

Applications

Our Abpromise guarantee covers the use of ab107170 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 44 kDa.

Target

  • Tissue specificityHighest expression in brain and testis.
  • Involvement in diseaseDefects in BSCL2 are the cause of congenital generalized lipodystrophy type 2 (CGL2) [MIM:269700]. Congenital generalized lipodystrophy is an autosomal recessive disorder characterized by a near absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.
    Defects in BSCL2 are the cause of spastic paraplegia type 17 (SPG17) [MIM:270685]; also known as Silver spastic paraplegia syndrome. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. SPG17 is characterized by prominent amyotrophy of the hand muscles, the presence of mild to severe pyramidal tract signs, and spastic paraplegia. SPG17 is a motor neuron disease overlapping with distal spinal muscular atrophy type 5.
    Defects in BSCL2 are a cause of distal hereditary motor neuropathy type 5 (HMN5) [MIM:600794]; also known aS distal hereditary motor neuropathy type V (DSMAV). HMN5 is an autosomal dominant disorder characterized by degeneration of motor nerve fibers, predominantly in limb distal regions.
  • Sequence similaritiesBelongs to the seipin family.
  • Cellular localizationEndoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • Bernardinelli Seip congenital lipodystrophy 2 antibody
    • Bernardinelli Seip congenital lipodystrophy type 2 protein antibody
    • Bernardinelli-Seip congenital lipodystrophy type 2 protein antibody
    • BSCL 2 antibody
    • BSCL2 antibody
    • BSCL2_HUMAN antibody
    • GNG3LG antibody
    • HMN 5 antibody
    • HMN5 antibody
    • MGC4694 antibody
    • Seipin antibody
    • Spastic paraplegia 17 (autosomal dominant) antibody
    • Spastic paraplegia 17 (Silver syndrome) antibody
    • Spastic paraplegia 17 antibody
    • Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome) antibody
    • Spastic paraplegia with amyotrophy of hands and feet antibody
    • SPG 17 antibody
    • SPG17 antibody
    see all

Anti-BSCL2 antibody images

  • Anti-BSCL2 antibody (ab107170) at 1/100 dilution + NCI-H460 cell line lysates at 35 µg

    Predicted band size : 44 kDa

References for Anti-BSCL2 antibody (ab107170)

ab107170 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab107170.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"